Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy
· 2025-12-06
Links
DOI
PubMed
Journal
The Breast